Condition
Detrusor Hyperreflexia
Total Trials
5
Recruiting
0
Active
0
Completed
3
Success Rate
75.0%-12% vs avg
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
Termination Rate
20.0%
1 terminated out of 5 trials
Success Rate
75.0%
-11.5% vs benchmark
Late-Stage Pipeline
80%
4 trials in Phase 3/4
Results Transparency
133%
4 of 3 completed with results
Key Signals
4 with results75% success
Data Visualizations
Phase Distribution
5Total
P 1 (1)
P 3 (1)
P 4 (3)
Trial Status
Completed3
Terminated1
Unknown1
Trial Success Rate
75.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT03755089Phase 4Unknown
Oral vs Intravesical Analgesia for Office Bladder Botox Injections
NCT00667095Phase 3Terminated
Over Active Bladder Instillation Study - Botox
NCT00583219Phase 1Completed
Botulin-A Toxin Instillations and Overactive Bladder
NCT00224016Phase 4CompletedPrimary
Safety and Efficacy Study of Transdermal Oxybutynin to Treat Overactive Bladder With a Neurological Condition
NCT00224029Phase 4CompletedPrimary
A Study Evaluating Oxybutynin in Patients With Neurogenic Overactive Bladder Associated With a Neurological Condition
Showing all 5 trials